Can Anamorelin be used long term? Safety and potential risks of long-term use

Anamorelin is a drug used to improve appetite and weight. It is mainly used to treat anorexia and weight loss caused by cancer, especially for patients with non-small cell lung cancer and other malignant tumors. As an oral drug, anamorelin stimulates growth hormone secretion receptors and promotes the release of growth hormone in the body, thereby helping to improve appetite and increase weight. However, regarding the long-term use of anamorelin, although its efficacy has been recognized to some extent, there are also some safety and potential risk issues.

As a stimulant drug, the safety of long-term use of anamorelin is not completely clear. Existing clinical trials have mainly focused on short-term treatment, so there may be unknown safety issues with long-term use. Long-term use of anamorelin may cause fluctuations in hormone levels in the body, especially increases in growth hormone levels, which may burden the endocrine system. Especially in elderly patients or patients with underlying diseases such as cardiovascular disease and diabetes, long-term use of anamulin may increase the risk of related complications, such as hyperglycemia, hypertension, diabetes, etc. Therefore, long-term use requires regular health examinations under the guidance of a doctor, especially monitoring of blood sugar, blood lipids, and cardiovascular function.

Long-term use of anamorelin may cause a range of side effects. The most common side effects include edema, weight gain, and mild gastrointestinal discomfort, such as nausea and diarrhea. In addition, the potential burden of anamorelin on the liver cannot be ignored. Long-term use may increase the risk of abnormal liver function tests, particularly in those with pre-existing liver disease or long-term use of other medications. Although the side effects of anamorelin are relatively mild, you still need to be alert to possible adverse reactions caused by long-term use. In particular, changes in weight and edema during treatment require close attention.

Anamorelin promotes appetite and weight gain by increasing the secretion of growth hormone, a mechanism that may affect immune system function. Long-term use of anamorelin may cause changes in the regulation of the immune system, especially in patients with pre-existing immune deficiencies. Long-term use may make patients more susceptible to infection or immune dysfunction. At the same time, long-term use of anamorelin may also lead to metabolic abnormalities, especially increased fat accumulation and weight gain, which may have adverse effects on metabolism, especially glucose and lipid metabolism problems, such as diabetes and hyperlipidemia.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/